Caution:At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
see.ip - Details for 5-((HALOPHENYL)-3-HALO-PYRIDIN-2-YL)-NITRIL-DERIVATE ALS ZWISCHENPRODUKTE ZUR HERSTELLUNG VON [(5-(HALOPHENYL)-3-HYDROXYPYRIDIN-2-CARBONYL)-AMINO]ALKANSÄURE DERIVATE
Details for 2017191362
Up to date per 09.06.2026
Actions
Details for 2017191362
Title / Product Name
5-((HALOPHENYL)-3-HALO-PYRIDIN-2-YL)-NITRIL-DERIVATE ALS ZWISCHENPRODUKTE ZUR HERSTELLUNG VON [(5-(HALOPHENYL)-3-HYDROXYPYRIDIN-2-CARBONYL)-AMINO]ALKANSÄURE DERIVATE
Status
Granted/Registered
Protection Type
European Patent
(AT-) Application Number
2017191362
EP Publication Number
3290404
E-Number
1212059
Language
EN
PCT Number
-
Publication Date
07.03.2018 A
11.12.2019 B1
Registration Date
11.12.2019
AT Publication Date
15.12.2019
Application Date
05.06.2012
Registration Number
-
Priorities
06.06.2011
US
201161493536 P
IPC
C07D 213/81 20060101AFI20190531BHEP
Maximum Duration of Protection
05.06.2032
Owner
Akebia Therapeutics Inc.245 First Street, Suite 1100 Cambridge, MA 02142US